Clinical trials: Low Back Pain, Chronic

Low Back Pain

A Study on Efficacy (Effectiveness), Safety, and Impact on Quality of Life Measures of Dilaudid CR (Controlled Release);, Hydromorphone HCl in Patients With Chronic Low Back Pain

• Completed
• Age: 18 years and older
• Phase 2

The purpose of the study was to characterize the safety, effectiveness, and impact on quality of life (QOL) measures of OROS® hydromorphone HCL in patients with chronic low back pain.

Trial name

NCT00398788

Testing

OROS® hydromorphone HCL; Dilaudid CR (controlled release); Dilaudid IR (immediate release) as rescue medicine

Volunteers

207 people

Sponsor

Alza Corporation, DE, USA